BioSpace News Archive

Moderna, Inc., (Nasdaq: MRNA) today announced that Stéphane Bancel, Chief Executive Officer will participate in the MIT Laboratory for Financial Engineering (LFE) and Golub Center for Finance and Policy (GCFP) Distinguished Lecture Series, “Dealing with Coronavirus: An Industry Perspective” on Wednesday, April 1 from 4:30-6:00 p.m. EDT.

Financing co-led by Cobro Ventures and Taiwania Capital Management Corporation; Michael Huang, Managing Partner at Taiwania joins the Regenacy Board of Directors- WALTHAM, Mass.--( BUSINESS WIRE )-- Regenacy Pharmaceuticals , a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced the closing of a $30 million Series A financing. The financing was co-led by Cobro

Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its synthetic SARS-CoV-2 RNA Controls to provide quality control for the development, verification, and ongoing validation for diagnostic tests are now included on the U.S. Food and Drug Administration (FDA) website as refer

Astrotech Corporation [NASDAQ: ASTC] today announced that the BreathTest-1000™ is under development to screen for volatile organic compound (VOC) metabolites found in a person’s breath that could indicate they may have an infection, including Coronavirus Disease 2019 (“COVID-19”) or the resulting disease, pneumonia. The Company believes that its unique mass spectrometry technology that was initially developed in collabora

Acquisition aims to maximize synergy through combined technologies

Masimo (NASDAQ: MASI) today announced the results of a recently published ten-year retrospective study in which researchers at Dartmouth-Hitchcock Medical Center investigated the impact of an integrated clinical surveillance monitoring system, using Masimo SET® and Patient SafetyNet™ technologies, on mortality related to use of prescribed opioids in the general ward.

NTT Research PHI Lab Director to Support Coherent Ising Machines (CIMs) Initiative

DarioHealth® Receives Endorsement from the Organization for the Review of Care & Health Applications (ORCHA)

Data is beginning to emerge on how the new Coronavirus and the infection it causes, N-CoV19, affects pregnancy, delivery, fertility and fertility treatments.

Ohana Biosciences, a clinical-stage biotechnology company pioneering reproductive health through the industry’s first sperm biology platform, today announced the appointment of David Sable, M.D., to its Board of Directors. A world-renowned reproductive endocrinologist, Dr. Sable brings more than 30 years of reproductive health and medical expertise to Ohana. Dr. Sable currently directs healthcare and life sciences inve